Posted by Michael Wonder on 27 Nov 2018
CMS takes action to lower prescription drug costs by modernising Medicare
26 November 2018 - Proposed regulation for Medicare Parts C & D would strengthen negotiations with prescription drug manufacturers to lower costs and increase transparency for patients.
Today, the CMS proposed polices for 2020 to strengthen and modernise the Medicare Part C and D programs.
The proposal would ensure that Medicare Advantage and Part D plans have more tools to negotiate lower drug prices, and the agency is also considering a policy that would require pharmacy rebates to be passed on to seniors to lower their drug costs at the pharmacy counter.
